Name And Identifier
ID: ALA1736915
Max Phase: Preclinical
Molecular Formula: C23H22N4O4
Molecular Weight: 418.45
Molecule Type: Small molecule
Representations
Molfile:
Canonical SMILES:
Standard InChI:
Standard InChI Key:
Alternative Forms
Molecule Features
| Natural Product: No | Chemical Probe: No |
| Molecule Type: Small molecule | First In Class: No |
| Chirality: No | Prodrug: No |
| Oral: No | Parenteral: No |
| Topical: No | Black Box: No |
| Availability: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | Target Name | Target Type | Target Organism | Binding Site Name |
|---|
Activity Summary
| Bioactivity Summary | Count |
|---|---|
| Potency | 6 |
| Assay Summary | Count |
|---|---|
| F-Functional | 6 |
Properties
| Molecular Weight: 418.45 | Molecular Weight (Monoisotopic): 418.1641 |
| AlogP: 3.79 | #Rotatable Bonds: 6 |
| Polar Surface Area: 101.58 | Molecular Species: NEUTRAL |
| HBA: 7 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 |
| HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.05 | CX Basic pKa: 1.42 |
| CX LogP: 3.57 | CX LogD: 3.57 |
| Aromatic Rings: 4 | Heavy Atoms: 31 |
| QED Weighted: 0.51 | Np Likeness Score: -2.05 |
Source
Source(1):